The global digital PCR market is projected to reach USD 12.4 billion by 2028, growing at a CAGR of 7.8% from USD 8.5 billion in 2023. This growth is driven by factors such as the increasing incidence of infectious diseases and genetic disorders, advancements in PCR technologies, and rising investments in the field. The qPCR reagents and consumables segment holds the largest market share, supported by the automation and miniaturization of instruments, advanced software, and customized laboratory reagents.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204
Reagents and consumables for qPCR and dPCR hold the largest market share in the global dPCR and qPCR market. The qPCR reagents and consumables segment is expected to dominate the market in 2023. Researchers and healthcare professionals increasingly utilize dPCR and qPCR products due to automation and miniaturization of instruments, advanced software, and customized laboratory reagents. The adoption of MIQE guidelines globally is also driving the use of qPCR and dPCR reagents. The expanding applications of qPCR, with its technological advantages over traditional PCR, such as real-time analysis and reduced analysis time, are expected to fuel the growth of the reagents and consumables market.
In terms of application, the clinical segment holds the largest share in the qPCR and dPCR market. It is estimated to dominate the market during the forecast period. Factors driving this growth include the growing usage of qPCR in disease diagnosis, increasing incidence of infectious and genetic diseases, and the emphasis on early and effective disease diagnosis and treatment.
Similarly, in the digital PCR (dPCR) market, the clinical applications segment is expected to hold the largest share in 2022. The technological benefits offered by dPCR over qPCR and traditional PCR, such as high flexibility, increased device sensitivity, better precision, and absolute quantification of target molecules, drive its adoption in hospitals, diagnostic centers, and research institutions. The increasing global burden of cancer and AIDS further contributes to the growth of the clinical applications segment. Factors such as growing usage of qPCR in disease diagnosis, rising incidence of infectious and genetic diseases, and the emphasis on early and effective disease diagnosis and treatment also drive the market growth of the clinical applications segment.
Get 10% Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=174151204
North America leads the dPCR and qPCR market, followed by Europe, due to factors like the adoption of innovative genomic analysis products, research funding, and widespread use of PCR techniques in clinical diagnostics and forensics. Key players in the market include Thermo Fisher Scientific, Danaher Corporation, and F. Hoffmann-La Roche, Ltd.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441